Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026)
Vycor Medical (VYCO) reported Net Income towards Common Stockholders of -$142077.0 for Q1 2026, up 29.23% year-over-year from -$109944.4 in Q1 2025, and down 126.65% quarter-over-quarter from -$62686.0 in Q4 2025.
Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$142077.0 in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$142077.0, up 29.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$338125.0 (up 23.07% YoY), and the FY2025 annual result was -$396796.0, up 8.06% from the prior year.
- Net Income towards Common Stockholders declined to -$142077.0 in Q1 2026 per VYCO's latest filing, from -$62686.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $68406.0 in Q2 2023 and troughed at -$276992.0 in Q3 2022.
- A 5-year average of -$123164.2 and a median of -$142077.0 in 2026 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders plunged 956.22% in 2022, then soared 337.97% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$116548.0 in 2022, then rose by 20.16% to -$93055.0 in 2023, then jumped by 92.76% to -$6737.0 in 2024, then plunged by 830.47% to -$62686.0 in 2025, then plunged by 126.65% to -$142077.0 in 2026.
- Business Quant data shows VYCO's Net Income towards Common Stockholders at -$142077.0 in Q1 2026, -$62686.0 in Q4 2025, and -$157249.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Vycor Medical | - | - | 375,153.00 | -142,077.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,077.00 |
| Dec 31, 2025 | -62,686.00 |
| Sep 30, 2025 | -157,249.00 |
| Jun 30, 2025 | 23,887.00 |
| Mar 31, 2025 | -200,748.00 |
| Dec 31, 2024 | -6,737.00 |
| Sep 30, 2024 | -222,002.00 |
| Jun 30, 2024 | -10,038.00 |
| Mar 31, 2024 | -192,793.00 |
| Dec 31, 2023 | -93,055.00 |
| Sep 30, 2023 | -214,089.00 |
| Jun 30, 2023 | 68,406.00 |
| Mar 31, 2023 | -155,323.00 |
| Dec 31, 2022 | -116,548.00 |
| Sep 30, 2022 | -276,992.00 |
| Jun 30, 2022 | -99,010.00 |
| Mar 31, 2022 | -236,737.00 |
| Dec 31, 2021 | -187,062.00 |
| Sep 30, 2021 | -158,492.00 |
| Jun 30, 2021 | -9,374.00 |